Potential use of endothelial progenitor cells for regeneration of the vasculature

Therapeutic Advances in Cardiovascular Disease
Kenichi Yamahara, Hiroshi Itoh

Abstract

Over the past decade, interest has been generated in the study of endothelial progenitor cells (EPCs). EPCs have been studied for their role in endogenous maintenance and for their therapeutic potential in vascular regenerative medicine. Despite their obvious potential in clinical practice, there still remain many controversies regarding how EPCs actually enhance endothelial repair and neovascularization. In addition, because of the limited expansion ability of EPCs, expansion of sufficient EPC populations for therapeutic angiogenesis remains a major task. On the other hand, embryonic stem (ES) cells have an extended self-renewal activity and can be expanded without limit, thus ES-cell-derived endothelial cells could be feasible as a novel cell source for therapeutic angiogenesis. In this review, we discuss recent experimental and clinical findings of EPCs and human ES-cell-derived endothelial cells for the treatment of ischemic cardiovascular diseases.

References

Sep 8, 1999·Science·B L ZieglerC Peschle
Jan 5, 2000·The Journal of Clinical Investigation·Y LinR P Hebbel
Jun 7, 2000·The Journal of Clinical Investigation·T MuroharaT Imaizumi
Aug 10, 2000·Differentiation; Research in Biological Diversity·B Fernandez PujolK Havemann
Apr 5, 2001·Nature·D OrlicP Anversa
Jun 8, 2001·The Journal of Clinical Investigation·K A JacksonM A Goodell
Jul 19, 2001·Annals of the New York Academy of Sciences·D OrlicP Anversa
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·D OrlicP Anversa
Oct 18, 2002·Blood·Elvira PelosiCesare Peschle
Jan 9, 2003·Lancet·Christof StammGustav Steinhoff
Feb 14, 2003·The New England Journal of Medicine·Jonathan M HillToren Finkel
Oct 4, 2003·Blood·Ferdinand H BahlmannDanilo Fliser
Oct 9, 2003·Kidney International·Ferdinand H BahlmannDanilo Fliser
Nov 15, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Jacob GeorgeGad Keren
Dec 31, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Jin HurYoung-Bae Park
Mar 6, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Masashi OhtsukaIssei Komuro
Jun 12, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Takahisa KondoToyoaki Murohara
Oct 19, 2004·Journal of the American College of Cardiology·Volker SchächingerAndreas M Zeiher
Dec 4, 2004·Stroke; a Journal of Cerebral Circulation·Usman GhaniKathryn Todd

❮ Previous
Next ❯

Citations

Mar 13, 2012·Clinical Oral Investigations·Thomas ZiebartBilal Al-Nawas
Apr 9, 2010·Clinical and Experimental Pharmacology & Physiology·Karen L AndrewsJaye P F Chin-Dusting
Dec 17, 2009·European Journal of Clinical Pharmacology·Natália AntónioLuís A Providência
Mar 15, 2011·Advanced Drug Delivery Reviews·Esther C NovoselPetra J Kluger
Jul 28, 2009·Journal of Thrombosis and Haemostasis : JTH·X Li, L Claesson-Welsh
Jun 29, 2011·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Maria PaprockaClaudine Kieda
Mar 22, 2012·Microscopy Research and Technique·Gaetano Scala, Lucianna Maruccio
Oct 29, 2015·BioMed Research International·Carmela R BalistreriGiuseppe Mazzesi
Jan 1, 2010·Therapeutic Advances in Cardiovascular Disease·Catharina NesselmannGustav Steinhoff
Aug 15, 2009·Circulation Research·Katrin SchröderRalf P Brandes
May 11, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Arun H S Kumar, Noel M Caplice
Oct 17, 2009·Journal of Cardiovascular Pharmacology·Cristiano SpadaccioMassimo Chello
Mar 20, 2010·Neural Computation·Laurent U Perrinet
May 16, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Bianca Schröder-HeurichFrauke von Versen-Höynck
Dec 21, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Catherine A LemariéErnesto L Schiffrin
Mar 31, 2011·Médecine sciences : M/S·Claire VinatierJoëlle Amédée
Nov 24, 2020·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Ethan J KilmisterSwee T Tan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.